[Table/Fig-2]:

Comparison in patient baseline characteristics.

Variable	Total (n = 150)	Olopatadine HCL 0.6% Group I (n = 75)	Fluticasone propionate Group II (n = 75)	t-value	p-value
AGE (years)
Mean(SD)	32.3 (9.43)	31.31 (9.90)	33.19 (8.89)	t=2.786	0.4258
Range	15 - 50	15 - 50	15 - 50
Gender
Male	86	35	51	χ2= 6.9771	0.0082
Female	64	40	24
Symptoms
Intermittent	87	45	42	χ2=0.2461	0.6196
Persistent	63	30	33
Duration of Illness (yrs) Mean (SD)	2.5 (1.3)	2.6 (1.3)	2.5 (1.3)	---	0.6118